Skip to main content

Meeting Presentations

Following are links to the presentations from the DGS Meeting held here at Vanderbilt on July 21-23, 2005.

“Pharmacology’s Future: Avoiding the Suffocation of the Bell Jar

Lee Limbird, Ph.D. Vice President for Research and Chair, Department of Biomedical Sciences,Meharry Medical College, Nashville, Tennessee


Dennis Hall, Assoc Provost Research and Graduate Education and Professor of Physics,Vanderbilt University, Nashville, Tennessee

Pharmacologists as Dinomammals: The Changing Face of Pharmacology 

Robert Gould, Ph.D., Senior Vice President, Merck Pharmaceuticals, Boston, Massachusetts

What the Pharmaceutical Industry requires for success” 

Marlene Cohen, Ph.D., Distinguished Lilly Fellow (retired), Eli Lilly and Company, Adjunct Professor of Pharmacology, Indiana University School of Medicine, and Vice President, Creative Pharmacology Solutions LLC, Carmel, Indiana

“The World of West Coast Biotechs: Needs and Opportunities” 

Franz F. Hefti, Ph.D., Executive Vice President, Drug Development, Rinat Neuroscience, Palo Alto, California

An Academic Perspective to ‘Marketing’ Pharmacology

Barbara Beckman, Ph.D., Professor of Pharmacology and Assistant Dean of Admissions, Tulane Medical School, New Orleans, Louisiana

“Interdisciplinary Umbrella Programs…perceptions on the Vanderbilt IGP after 14 years” 

Roger Chalkley, D. Phil., Senior Associate Dean, Biomedical Research Education & Training, Vanderbilt University, Nashville, Tennessee

Representing the Underrepresented 

Lou DeFelice, Ph.D., Professor of Pharmacology and Neuroscience, Director of the Vanderbilt Bridges Program, Vanderbilt University, Nashville, Tennessee

Task Force on Learning Objectives for Graduate Students in Pharmacology 

J. R. Haywood, Ph.D., Professor and Chairperson, Pharmacology and Toxicology, MichiganState University, East Lansing, Michigan

Curriculum Presentations

Richard Robinson, PhD, Columbia University

Lonny Levin, PhD, Cornell University 

David Riddick, PhD, University of Toronto 

Lee Graves, PhD, University of North Carolina at Chapel Hill 

Robert Speth, PhD, University of Mississippi 

Brian Knoll, PhD, University of Houston 

Edward Morgan, PhD, Emory University

Breakout Sessions:


VICC Room A Topic

VICC Room B Topic

VICC Room C Topic

Session 1:


3:15 pm – 4:00 pm

Undergraduate Programs

 (Discussion Leader: B. Beckman)



 Umbrella Programs

(Discussion Leaders: R. Chalkley and J. Barnett)



 Master’s Degrees

(Discussion Leaders: JR Haywood, J. Lucot)


Session 2:


4:00 pm – 4:45 pm

Curriculum Issues

(Discussion Leader: R. Robinson)



Minority  Issues

(Discussion Leader: L. DeFelice)



(Discussion Leaders: P. Preusch & A. Zajicek)


Session 3:


4:45 pm – 5:30 pm

Curriculum Issues

(Discussion Leader: Y. Tu)


Umbrella Programs

(Discussion Leader: R. Chalkley)



(Discussion Leaders: P. Preusch & A. Zajicek)


Business Meeting

Joey Barnett, Ph.D., Vice-Chair in Pharmacology, Director of Graduate Studies in Pharmacology, Associate Professor of Pharmacology, Medicine and Microbiology & Immunology, Vanderbilt University, Nashville, Tennessee

“Pharmacological Sciences Training Grants – Progress Report” 

Peter Preusch, Ph.D., NIGMS Training Grant Program Director, National Institutes of Health,Bethesda, Maryland

“Pediatric Clinical Pharmacology: What’s new at the NIH” 

Anne Zajicek, M.D./Pharm.D., Pediatric Medical Officer, National Institutes of Health, Bethesda,Maryland 

During this historic meeting, we asked participants to complete a questionnaire/survey of their Pharmacology program.  Dr. Barnett presented some of the preliminary data during the Business Meeting (see link, above).  For the blind final data analysis, click here.  For comments on the challenges and opportunities faced by various institutions, click here. If you prefer the unblinded data, please contact Dr. Barnett at and he will be happy to accommodate your request.

To access a PowerPoint summary of the data, click here.